Dyne Therapeutics (DYN) Other Non Operating Income (2019 - 2026)

Dyne Therapeutics (DYN) has 8 years of Other Non Operating Income data on file, last reported at $4.4 million in Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 36.93% year-over-year to $4.4 million in Q1 2026; TTM through Mar 2026 was $19.4 million, a 35.33% decrease from a year earlier, with the FY2025 full-year figure at $22.0 million, down 16.99% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $4.4 million, up from $4.2 million in the prior quarter.
• Over the last five years, Other Non Operating Income for DYN reached as high as $8.5 million in Q3 2024 and fell as low as $200000.0 in Q1 2022.
• Historically, Other Non Operating Income has averaged $3.6 million across 5 years, with a median of $3.5 million in 2024.
• Across the five-year window, Other Non Operating Income jumped 657.47% in 2022 and plunged 44.83% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at $1.3 million in 2022, then dropped by 20.33% to $1.0 million in 2023, then soared by 620.57% to $7.6 million in 2024, then tumbled by 44.83% to $4.2 million in 2025, then advanced by 5.94% to $4.4 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $4.4 million in Q1 2026, $4.2 million in Q4 2025, and $5.9 million in Q3 2025.